{"version":"1.0","type":"rich","provider_name":"NULLPEN","provider_url":"https://nullpen.com","title":"Trial results posted: A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis","cache_age":300,"width":400,"height":320,"html":"<iframe src=\"https://nullpen.com/embed?story=sha256%3A07b4ddc4387044c69a2b2bd3f548c1fa5100cb999baa18baf22346cc7e8cfa9b\" title=\"Trial results posted: A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis\" width=\"400\" height=\"320\" loading=\"lazy\" style=\"border:0;max-width:100%\" referrerpolicy=\"strict-origin-when-cross-origin\" sandbox=\"allow-popups allow-popups-to-escape-sandbox\"></iframe>"}